Anandamide enhances IL-10 production in activated microglia by targeting CB2receptors: Roles of ERK1/2, JNK, and NF-κB

Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E2

(2008) Fernando Correa et al.   BIOCHEMICAL JOURNAL

A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells

(2008) Fernando Correa et al.   BIOCHEMICAL PHARMACOLOGY

Therapeutic potential of CB2 targeting in multiple sclerosis

(2008) Fabian Docagne et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Strategies for use of IL-10 or its antagonists in human disease

(2008) Anne O'Garra et al.   IMMUNOLOGICAL REVIEWS

Thyroid Hormone-Mediated Activation of the ERK/Dual Specificity Phosphatase 1 Pathway Augments the Apoptosis of GH4C1 Cells by Down-Regulating Nuclear Factor-κB Activity

(2008) Antonio Chiloeches et al.   MOLECULAR ENDOCRINOLOGY

CB2cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies

(2007) Arévalo-Martín et al.   BRITISH JOURNAL OF PHARMACOLOGY

Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling

(2005) Fernando Correa et al.   BRITISH JOURNAL OF PHARMACOLOGY